ATH alterity therapeutics limited

Ann: Alterity Presents Encouraging New Phase 2 Data in MSA, page-27

  1. 14,651 Posts.
    lightbulb Created with Sketch. 1583
    “We look forward to engaging with the U.S. Food and Drug Administration and other regulatory authorities as we seek to advance the development of this potentially disease modifying therapy for individuals living with MSA.”

    Im not a Scientist so i’m happy to read others opinions

    Simple Question ?
    All this info re 50 mg against 75 mg etc ( discrepancy)
    this info was out there when we raised $40 million
    Note..
    Don’t you think that JPMorgan Chase .. Regal…Blackrock would have done their DD? Before investing..


    Last edited by itsagas: 11/04/25
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
1.1¢
Change
0.000(0.00%)
Mkt cap ! $100.4M
Open High Low Value Volume
1.0¢ 1.1¢ 1.0¢ $60.81K 5.737M

Buyers (Bids)

No. Vol. Price($)
37 16255465 1.0¢
 

Sellers (Offers)

Price($) Vol. No.
1.1¢ 1643984 2
View Market Depth
Last trade - 16.10pm 13/06/2025 (20 minute delay) ?
ATH (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.